Infliximab Reduces the Frequency of Interleukin 17-Producing Cells and the Amounts of Interleukin 17 in Patients With Rheumatoid Arthritis
Hui Shen, Liping Xia, Jing Lu, Weiguo Xiao
DOI: 10.2310/JIM.0b013e3181eb9895 Published 15 December 2015
Hui Shen
From the Department of Rheumatology and Immunology, the 1st Affiliated Hospital of China Medical University, Shenyang, China.
PhDLiping Xia
From the Department of Rheumatology and Immunology, the 1st Affiliated Hospital of China Medical University, Shenyang, China.
PhDJing Lu
From the Department of Rheumatology and Immunology, the 1st Affiliated Hospital of China Medical University, Shenyang, China.
PhDWeiguo Xiao
From the Department of Rheumatology and Immunology, the 1st Affiliated Hospital of China Medical University, Shenyang, China.
PhD
Submit a Response to This Article
No eLetters have been published for this article.
Infliximab Reduces the Frequency of Interleukin 17-Producing Cells and the Amounts of Interleukin 17 in Patients With Rheumatoid Arthritis
Hui Shen, Liping Xia, Jing Lu, Weiguo Xiao
Journal of Investigative Medicine Oct 2010, 58 (7) 905-908; DOI: 10.2310/JIM.0b013e3181eb9895